Equillium (EQ)
Develops EQ504, an investigational AhR modulator for ulcerative colitis and other inflammatory diseases.
$2.20
Pre-market−0.06 (−2.65%)
At close$2.26(+2.49%)
Something off on this page? Send us feedback.
Next report
Nov 12, 2026
in 70 days
EPS estimate
−$0.05
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.16−$0.24−$0.16−$0.06−$0.04−$0.06−$0.04Pending
Estimate−$0.22−$0.23−$0.14−$0.14−$0.07−$0.04−$0.05−$0.05
Surprise+27.3%−4.3%−14.3%+57.1%+42.9%−50.0%+25.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$4.4M——————Pending
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.05 | — | — |
| Aug 2026 | −$0.05 | −$0.04 | +25.9% |
| May 2026 | −$0.04 | −$0.06 | −50.0% |
| Mar 2026 | −$0.07 | −$0.04 | +42.9% |
| Nov 2025 | −$0.14 | −$0.06 | +57.1% |
The latest year is open to everyone — the 33 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Oct 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.05 | — | — | — | — | — | — |
| Aug 13, 2026 | −$0.05 | −$0.04 | +25.9% | — | — | — | +17.4% |
| May 13, 2026 | −$0.04 | −$0.06 | −50.0% | — | — | — | +12.1% |
| Mar 25, 2026 | −$0.07 | −$0.04 | +42.9% | — | — | — | 0.0% |
| Nov 13, 2025 | −$0.14 | −$0.06 | +57.1% | — | — | — | +23.8% |
The latest year is open to everyone — the 33 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 14, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 13, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 25, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 14, 2022 | |||||||
| Aug 15, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 23, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 24, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 13, 2020 | |||||||
| Mar 26, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 12, 2019 | |||||||
| May 13, 2019 | |||||||
| Mar 27, 2019 | |||||||
| Nov 15, 2018 | |||||||
| Oct 12, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||